Orphazyme announces the upcoming appointment of Andrew Mercieca to its Board of Directors

– DENMARK, Copenhagen –  Orphazyme A/S (CPH: ORPHA), a late-stage biopharmaceutical company, today announced the appointment of Andrew Mercieca to its Board of Directors, effective on April 7, 2022, to succeed Catherine Moukheibir who will step down from the Board as of December 9, 2021.

Concurrently, he has been appointed as Board Observer and Consultant

“Andrew brings a strong financial skill set combined with an understanding of the international life sciences sector to Orphazyme and I very much look forward to working with himsaid Board Chairman, Georges Gemayel.

Andrew will take over as Chairman of the Audit Committee.

The Board of Directors will consist of

  • Georges Gemayel, Chairman,
  • Bo Jesper Hansen, Deputy Chairman,
  • Carrolee Barlow,
  • Martin Bonde,
  • Stephanie Smith Okey.

About Andrew Mercieca

Andrew Mercieca has over 25 years of experience in international finance, has held multiple positions in the healthcare sector, and is currently CFO of LifeArc, a UK medical research charity focussed on the translation of scientific discoveries and innovations for the benefit of patients.

About Orphazyme A/S

Orphazyme is a late-stage biopharmaceutical company developing arimoclomol for Niemann-Pick disease type C. Orphazyme is headquartered in Denmark and has operations in the U.S. and Switzerland. ADSs representing Orphazyme’s shares are listed on The Nasdaq Global Select Market and its shares are listed on Nasdaq Copenhagen.

For more information : https://www.orphazyme.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

Talent4Boards Team